MSME (Udyam registered) Ministry of MSME
- Category
- Medium (2023-24)
- Udyam number
- UDYAM-UK-06-0002198
Canixa Life Sciences Private Limited. - pharma in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹201.5 Cr
▲ 19% YoY
Net profit · FY 2025
₹16.74 Cr
Net margin 8.3%
EBITDA · FY 2025
₹27.96 Cr
EBITDA margin 13.9%
Authorised capital
₹75 Lakh
Registered with MCA
Paid-up capital
₹63.5 Lakh
Issued & subscribed
Open charges
₹37.13 Cr
Satisfied ₹2.45 Cr
Company age
19 yrs
Est. 2007
Employees · EPFO
892
Provident fund records
About Canixa Life Sciences Private Limited.
Data last updated:
Canixa Life Sciences Private Limited. is a private limited company based in Delhi, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 22 May 2007 and has been in existence for over 19 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24233DL2007PTC163800. Its GSTIN is 07AADCC5579L1Z6 (Delhi). The company holds 14 GST registrations, all of them active.
The company has an authorised share capital of ₹75 Lakh and a paid-up capital of ₹63.5 Lakh. It is led by directors Rupa Kanungo and Pravat Kumar Kanungo.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2024. The registered office is at 147 Doctors Apartment Vashundhara Enclave, Delhi, India – 110096.
As per the financials filed for FY 2025, the company reported a revenue of ₹201.5 Cr, a growth of 19% compared to the previous year. For the same year it recorded a net profit of ₹16.74 Cr (net margin 8.3%) and EBITDA of ₹27.96 Cr (EBITDA margin 13.9%). Revenue has grown at a compounded annual rate (CAGR) of 28% over three years and 18% over five years.
The company has about 892 employees on its provident fund (EPFO) records.
The company is associated with 1 brand: Canixa Life Sciences. As per MCA filings, the company has open charges of ₹37.13 Cr and satisfied charges of ₹2.45 Cr on record. Court records list 10 cases involving the company, including 3 filed by the company and 5 filed against it; 2 cases are pending. The company has 6 deals on record (5 rights issues, 1 funding round), with disclosed funding of ₹12.6 Lakh; the latest was in March 2019. Its 10 peer companies in the Pharma industry (Formulations) are compared by revenue, 5 larger and 5 smaller; the largest is Radison Labs Private Limited with revenue of ₹202.11 Cr.
Canixa Life Sciences Private Limited. is registered as a medium enterprise under the Udyam registration framework (Reg. No. UDYAM-UK-06-0002198). The current compliance status is marked as compliant by the Registrar of Companies. For more details, the company can be reached via its website canixalife.com.
Company Details of Canixa Life Sciences Private Limited.
CIN U24233DL2007PTC163800
Registration Number 163800
Incorporation Date 22 May 2007
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2024
Compliance Status Active Compliant
MSME Classification Medium
Udyam Registration UDYAM-UK-06-0002198
Recognitions & Rankings of Canixa Life Sciences Private Limited
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered Address147 Doctors Apartment Vashundhara Enclave, Delhi, India – 110096
- IndustryPharma, Drug Formulation & Development
Comprehensive company report
Canixa Life Sciences Private Limited. - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Associated Brands with Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited operates one associated brand: Canixa Life Sciences. Each brand links to its own profile.
| Brand | Description | Website |
|---|---|---|
| Pharmaceutical manufacturing and healthcare solutions focused on dermatological products in India. | canixalife.com |
Business Activity of Canixa Life Sciences Private Limited.
The main business activity of Canixa Life Sciences Private Limited is trade. In detail, this covers wholesale trading.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Canixa Life Sciences Private Limited. FY 2024 filings available
Canixa Life Sciences Private Limited. reported revenue of ₹201.5 Cr (up 19% YoY) for FY 2025.
Revenue · FY 2025
₹201.5 Cr ▲ 19%
Net profit · FY 2025
₹16.74 Cr margin 8.3%
EBITDA · FY 2025
₹27.96 Cr margin 13.9%
Compounded Annual Growth Rate (CAGR) of Canixa Life Sciences Private Limited.
Revenue CAGR growth
1 year
▲ 19%
3 years · compounded
▲ 28%
5 years · compounded
▲ 18%
EBITDA CAGR growth
1 year
▲ 38%
3 years · compounded
▲ 32%
5 years · compounded
▲ 31%
Revenue has grown at a compounded annual rate (CAGR) of 18% over five years, including 19% growth in the latest year. EBITDA rose 38% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Canixa Life Sciences Private Limited.
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹27.96 Cr | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹16.74 Cr | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Canixa Life Sciences Private Limited.
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 13.9% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 8.3% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Canixa Life Sciences Private Limited are in the company report.
Premium access
Financial statements from 2015
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited has 2 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rupa Kanungo | Director | 22 May 2007 | 19 Years 4 Months | Current |
| Pravat Kumar Kanungo | Director | 22 May 2007 | 19 Years 4 Months | Current |
Peer Comparison of Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited. is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Radison Labs Private Limited | ₹202.11 Cr (FY 2025) | •••• | •••• | 43.0% | •••• | Hyderabad, Telangana, India |
| Topnotch Chemicals Pvt Ltd | ₹201.92 Cr (FY 2024) | •••• | •••• | -14.0% | •••• | Navi Mumbai, Maharashtra, India |
| Finecure Pharmaceuticals Limited | ₹201.85 Cr (FY 2025) | •••• | •••• | -9.0% | •••• | Ahmedabad, Gujarat, India |
| Val Organics Private Limited | ₹201.8 Cr (FY 2025) | •••• | •••• | -16.0% | •••• | Mumbai, Maharashtra, India |
| Astral Steritech Private Limited | ₹201.59 Cr (FY 2022) | •••• | •••• | -36.0% | •••• | Vadodara, Gujarat, India |
| Canixa Life Sciences Private Limited. this company | ₹201.5 Cr (FY 2025) | •••• | •••• | 19.0% | •••• | Delhi, India |
| Synergia Life Sciences Private Limited | ₹201.39 Cr (FY 2024) | •••• | •••• | -22.0% | •••• | Wada, Maharashtra, India |
| Believe International Limited | ₹200.99 Cr (FY 2025) | •••• | •••• | 22.0% | •••• | Mangrol, Gujarat, India |
| Precise Biopharma Private Limited | ₹200.73 Cr (FY 2025) | •••• | •••• | 18.0% | •••• | Mumbai, Maharashtra, India |
| Unique Biotech Limited | ₹198.58 Cr (FY 2024) | •••• | •••• | 16.0% | •••• | Hyderabad, Telangana, India |
| Makson Pharmaceuticals (India) Private Limited | ₹198.26 Cr (FY 2025) | •••• | •••• | 4.0% | •••• | Wadhwancity, Gujarat, India |
Peers are the five companies nearest above and the five nearest below Canixa Life Sciences Private Limited by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited. is audited by LALIT AGARWAL AND COMPANY for the financial year 2024.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| LALIT AGARWAL AND COMPANY | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Canixa Life Sciences Private Limited.
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Canixa Life Sciences Private Limited.
Open charges
₹37.13 Cr
Satisfied charges
₹2.45 Cr
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 27 May 2025 | Others | ₹75.5 Lakh | Open |
| 12 Nov 2024 | Hdfc Bank Limited | ₹15 Lakh | Open |
| 27 Nov 2023 | Others | ₹68 Lakh | Open |
| 09 Feb 2023 | Hdfc Bank Limited | ₹23.6 Lakh | Open |
| 16 Dec 2015 | Hdfc Bank Limited | ₹35.31 Cr | Open |
Total charge records: 10 View all charges
Deals & Funding of Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited. has 6 deals on record (5 rights issues, 1 funding round), with disclosed funding of ₹12.6 Lakh; the latest was in March 2019.
Total deals
6
Rights issues
5
Funding round
1
Disclosed funding
₹12.6 Lakh
Deals on record (5 of 6)
| When | Deal | Amount | Parties |
|---|---|---|---|
| Mar 2019 | Rights issue | ₹40.5 Lakh | Investors: 2 individuals |
| Mar 2018 | Rights issue | ₹43.5 Lakh | Investors: 2 individuals |
| Mar 2017 | Rights issue | ₹40 Lakh | Investors: 2 individuals |
| Sep 2015 | Rights issue | ₹40.7 Lakh | Investors: 2 individuals |
| Mar 2015 | Rights issue | ₹15.8 Lakh | Investors: 2 individuals |
Premium access
Full deal history
All 6 deals with amounts, valuations, instruments and every party are in the company report.
- Every funding round and share transfer
- Amounts and valuations
- Investors, buyers and sellers
- Instruments and deal dates
Verified entity values are shown only after access is granted.
Deal records are compiled from filings and public sources; amounts are shown only where the source reported them.
Legal Cases of Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited. has 10 court cases on record: 3 filed by Canixa Life Sciences Private Limited, 5 filed against it, 2 where it is another party. 2 cases are pending and 8 are disposed. Status as checked between 21 Sep 2026 and 03 Oct 2026.
Total cases
10
Filed by the company
3
Filed against the company
5
Pending
2
Disposed
8
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 7 | 4 | 2 |
| High courts | 3 | 1 | 0 |
Cases on record (5 of 10)
| Court | Type of case | Party | Status |
|---|---|---|---|
| District court, East, Delhi | Cheque dishonour complaint | Filed by the company against Six Senses Financial Services Private Limited | Pending |
| District court, Shahdara, Delhi | Criminal case | Filed against the company by Affy Pharma Private Limited | Disposed |
| District court, Central, Delhi | Criminal case | Company is another party | Pending |
| High Court of Delhi | Court case (CRL.M.C.) | Filed against the company by an individual | Disposed |
| High Court of Uttarakhand | Court case (WPMS) | Filed by the company against an individual | Disposed |
Premium access
Full case history
All 10 cases with case numbers, court, year-wise trend, opposite parties and decision dates are in the company report.
- Every case with its case number
- Year-wise trend
- Opposite parties
- Decision dates and orders
Verified entity values are shown only after access is granted.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
Employees and EPFO Compliance at Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited. has a workforce of 892 employees as of Mar 29, 2025.
Employee count
892
Active EPFO establishments
3
Employee growth
3.84%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited. has 2 board changes on record since 2007: 2 appointments. The latest: Pravat Kumar Kanungo was appointed as Director on 22 May 2007.
AGM
Canixa Life Sciences Private Limited. last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Charges
A charge with Hdfc Bank Limited of Rs. 3,530.95 Lakh registered on 16 Dec 2015 with Charge ID 10613855 was modified on 19 Aug 2025.
Charges
A charge with Others amounted to Rs. 75.50 Lakh with Charge ID 101112125 was registered on 27 May 2025.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 15.00 Lakh with Charge ID 101022370 was registered on 12 Nov 2024.
Filing
Canixa Life Sciences Private Limited. has filed its annual Financial statements for the year ended 31 Mar 2024 with Roc Delhi.
Charges
A charge registered on 30 Jul 2019 via Charge ID 100286022 with Hdfc Bank Limited was fully satisfied on 08 Feb 2024.
Charges
A charge registered on 30 Jul 2019 via Charge ID 100286025 with Hdfc Bank Limited was fully satisfied on 08 Jan 2024.
Charges
A charge with Others amounted to Rs. 68.00 Lakh with Charge ID 100852344 was registered on 27 Nov 2023.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 23.60 Lakh with Charge ID 100705062 was registered on 09 Feb 2023.
Charges
A charge registered on 30 Jul 2019 via Charge ID 100286023 with Hdfc Bank Limited was fully satisfied on 07 Jul 2022.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 13.67 Lakh with Charge ID 100286023 was registered on 30 Jul 2019.
Charges
A charge with Hdfc Bank Limited amounted to Rs. 3.95 Lakh with Charge ID 100286025 was registered on 30 Jul 2019.
10 earlier events are listed in the company report.
Credit Ratings, Litigation & Regulatory Alerts for Canixa Life Sciences Private Limited.
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Canixa Life Sciences Private Limited.
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Canixa Life Sciences Private Limited.
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited has 14 GST registrations: 14 active. The first 4 active GSTINs are listed below.
Total GSTINs
14
Active
14
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07AADCC5579L1Z6 | Delhi | Active | 01 Jul 2017 |
| 05AADCC5579L1ZA | Uttarakhand | Active | 01 Jul 2017 |
| 29AADCC5579L1Z0 | Karnataka | Active | 01 Jul 2017 |
| 05AADCC5579L2Z9 | Uttarakhand | Active | 11 Jul 2017 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Canixa Life Sciences Private Limited.
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Canixa Life Sciences Private Limited.
Canixa Life Sciences Private Limited is an active private limited company based in Delhi, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 22 May 2007 (19+ years old) and is registered under CIN U24233DL2007PTC163800.
Canixa Life Sciences Private Limited reported revenue of ₹201.5 Cr for FY 2025 (up 19% YoY).
Canixa Life Sciences Private Limited has 2 current directors:
- Rupa Kanungo - Director
- Pravat Kumar Kanungo - Director
Canixa Life Sciences Private Limited reported a net profit of ₹16.74 Cr (net margin 8.3%) and EBITDA of ₹27.96 Cr (EBITDA margin 13.9%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Canixa Life Sciences Private Limited is 28% over three years and 18% over five years. In the latest year (FY 2025) revenue rose 19%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Canixa Life Sciences Private Limited is 07AADCC5579L1Z6, registered in Delhi. The company has 14 GST registrations in all, of which 14 are active. Other active GSTINs include 05AADCC5579L1ZA (Uttarakhand), 29AADCC5579L1Z0 (Karnataka), 05AADCC5579L2Z9 (Uttarakhand).
The CIN (Corporate Identification Number) of Canixa Life Sciences Private Limited is U24233DL2007PTC163800. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Canixa Life Sciences Private Limited has 10 court cases on record: 3 filed by the company and 5 filed against it. 2 are pending. Most are in the district courts.
Canixa Life Sciences Private Limited was incorporated on 22 May 2007, making it 19+ years old. It is registered with the Registrar of Companies, Delhi.
Canixa Life Sciences Private Limited has 6 deals on record (5 rights issues, 1 funding round), with disclosed funding of ₹12.6 Lakh; the latest was in March 2019.
The peers of Canixa Life Sciences Private Limited by revenue are Radison Labs Private Limited, Topnotch Chemicals Pvt Ltd, Finecure Pharmaceuticals Limited, Val Organics Private Limited, Astral Steritech Private Limited and 5 more, all in the Pharma industry (Formulations).